fluorodeoxyuridylate has been researched along with cyclin d1 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Banerjee, D; Bertino, JR; Danenberg, KD; Danenberg, PV; Hochhauser, D; Ju, JF; Lenz, HJ; Manno, DJ; Schmittgen, TC; Schönthal, AH; Spears, CP | 1 |
1 other study(ies) available for fluorodeoxyuridylate and cyclin d1
Article | Year |
---|---|
Restoration of wild-type p53 activity in p53-null HL-60 cells confers multidrug sensitivity.
Topics: Antineoplastic Agents; bcl-2-Associated X Protein; Cell Cycle; Cell Survival; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fluorodeoxyuridylate; Genes, bcl-2; Genes, p53; HL-60 Cells; Humans; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Transfection | 1998 |